Agendia raises $65 million

Agendia B.V. (Amsterdam, the Netherlands) raised $65 million in a financing led by Debiopharm Group. All existing investors participated, including Gilde Healthcare Partners; Van Herk Group; ING Corporate Investments; and Breedinvest, as well as new investor Korys and other undisclosed new investors. Last June, Agendia pulled an IPO on NYSE Euronext in Amsterdam to raise EUR 75 million ($110 million) (see BioCentury, June 27, 2011). ...